Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study

References

• LymperopoulosA, RengoG, KochWJ. The Adrenergic Nervous System in Heart Failure: pathophysiology and Therapy. Circ Res. 2013;113(6):6. doi:10.1161/CIRCRESAHA.113.300308
   Web of Science ®Google Scholar
• YancyCW, JessupM, BozkurtB, et al. American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239. doi:10.1016/j.jacc.2013.05.01923747642
   PubMed Web of Science ®Google Scholar
• MozaffarianD, BenjaminEJ, GoAS, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–e322. doi:10.1161/CIR.000000000000015225520374
   PubMed Web of Science ®Google Scholar
• GuoY, LipGY, BanerjeeA. Heart Failure in East Asia. Curr Cardiol Rev. 2013;9(2):112–122. doi:10.2174/1573403X1130902000423597295
   PubMedGoogle Scholar
• HobbsFDR, KenkreJE, RoalfeAK, DavisRC, HareR, DaviesMK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002;23(23):1867–1876. doi:10.1053/euhj.2002.325512445536
   PubMed Web of Science ®Google Scholar
• LiX, ZhangJ, HuangJ, et al. Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol. 2013;62(12):1065–1072. doi:10.1016/j.jacc.2013.05.03523747768
   PubMed Web of Science ®Google Scholar
• SongX, QuekRGW, GandraSR, CappellKA, FowlerR, CongZ. Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures. BMC Health Serv Res. 2015;15(1):245. doi:10.1186/s12913-015-0925-x26104784
   PubMed Web of Science ®Google Scholar
• ManurungD, TrisnohadiHB. Beta blockers for congestive heart failure. Acta Med Indones. 2007;39(1):44–48.17297209
   PubMedGoogle Scholar
• MihaiG, Colucci WilsonS, KarlS. β-Blockers in Chronic Heart Failure. Circulation. 2003;107(12):1570–1575. doi:10.1161/01.CIR.0000065187.80707.1812668487
   PubMed Web of Science ®Google Scholar
• Investigators, C.I. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353(9146):9–13. doi:10.1016/S0140-6736(98)11181-910023943
   PubMed Web of Science ®Google Scholar
• InvestigatorsCI. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001–2007. doi:10.1016/S0140-6736(99)04440-210376614
   PubMed Web of Science ®Google Scholar
• HjalmarsonA, GoldsteinS, FagerbergB, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283(10):1295–1302. doi:10.1001/jama.283.10.129510714728
   PubMed Web of Science ®Google Scholar
• PackerM, FowlerMB, RoeckerEB, et al. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002;106(17):2194–2199. doi:10.1161/01.cir.0000035653.72855.bf12390947
   PubMed Web of Science ®Google Scholar
• HeidenreichPA, LeeTT, MassieBM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997;30(1):27–34. doi:10.1016/s0735-1097(97)00104-69207617
   PubMed Web of Science ®Google Scholar
• MittalN, ShafiqN, ReddyS, MalhotraS, KumariS, VarmaS. Evaluation of efficacy of metoprolol in patients having heart failure with preserved ejection fraction: A randomized, double-blind, placebo-controlled pilot trial. Perspect Clin Res. 2017;8(3):124–131. doi:10.4103/2229-3485.21044928828307
   PubMedGoogle Scholar
• MengY, LiuX, LiuJ, ChengX. A prospective study on the impact of heart rate control achieved with metoprolol on cardiac performance, motor function and quality of life in Chinese chronic heart failure patients. Int J Cardiol. 2017;227:267–271. doi:10.1016/j.ijcard.2016.11.11527843047
   PubMed Web of Science ®Google Scholar
• GoldsteinG, MatersonBJ, CushmanWC, et al. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension. 1990;15(4):361–369. doi:10.1161/01.hyp.15.4.3612318518
   PubMed Web of Science ®Google Scholar
• HeadA, KendallMJ, FernerR, EaglesC. Acute effects of beta blockade and exercise on mood and anxiety. Br J Sports Med. 1996;30(3):238–242. doi:10.1136/bjsm.30.3.2388889119
   PubMed Web of Science ®Google Scholar
• GerstmanBB, JolsonHM, BauerM, ChoP, LivingstonJM, PlattR. The incidence of depression in new users of beta-blockers and selected antihypertensives. J Clin Epidemiol. 1996;49(7):809–815. doi:10.1016/0895-4356(96)00017-08691233
   PubMed Web of Science ®Google Scholar
• AhmedAIA, van MierloP, JansenP. Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol. Gen Hosp Psychiatry. 2010;32(6):646.e5-e7. doi:10.1016/j.genhosppsych.2010.04.008
   PubMedGoogle Scholar
• JiangW, KuchibhatlaM, CuffeMS, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004;110(22):3452–3456. doi:10.1161/01.CIR.0000148138.25157.F915557372
   PubMed Web of Science ®Google Scholar
• RanchordAM, SpertusJA, BuchananDM, GoschKL, ChanPS. Initiation of β-blocker therapy and depression after acute myocardial infarction. Am Heart J. 2016;174:37–42. doi:10.1016/j.ahj.2015.11.01826995368
   PubMed Web of Science ®Google Scholar
• KoellaWP. CNS-related (side-)effects of beta-blockers with special reference to mechanisms of action. Eur J Clin Pharmacol. 1985;28:Suppl:55–63. doi:10.1007/BF00543711
   PubMed Web of Science ®Google Scholar
• SoldinOP, MattisonDR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143–157. doi:10.2165/00003088-200948030-0000119385708
   PubMed Web of Science ®Google Scholar
• LuzierAB, KillianA, WiltonJH, WilsonMF, ForrestA, KazieradDJ. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther. 1999;66(6):594–601. doi:10.1053/cp.1999.v66.10340000110613615
   PubMed Web of Science ®Google Scholar
• LeeR, ChanY-H, WongJ, LauD, NgK. The 6-minute walk test predicts clinical outcome in Asian patients with chronic congestive heart failure on contemporary medical therapy: a study of the multiracial population in Singapore. Int J Cardiol. 2007;119(2):168–175. doi:10.1016/j.ijcard.2006.07.18917056135
   PubMed Web of Science ®Google Scholar
• GeorgiadouP, AdamopoulosS. Skeletal muscle abnormalities in chronic heart failure. Curr Heart Fail Rep. 2012;9(2):128–132. doi:10.1007/s11897-012-0090-z22430147
   PubMedGoogle Scholar
• WiklundI, WaagsteinF, SwedbergK, HjalmarssonA. Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial. Cardiovasc Drugs Ther. 1996;10(3):361–368. doi:10.1007/bf026279618877080
   PubMed Web of Science ®Google Scholar
• VologdinaIV EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE. Rational Pharmacotherapy in Cardiology. 2016 Accessed 414, 2020https://www.rpcardio.com/jour/article/view/541.
   Google Scholar
• CelikE, CayS, SensoyB, et al. Heart Failure Functional Class Associated with Depression Severity But Not Anxiety Severity. Acta Cardiol Sin. 2016;32(1):55–61. doi:10.6515/ACS20150509A27122931
   PubMed Web of Science ®Google Scholar
• LiuX, LouX, ChengX, MengY. Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders. Drug Des Devel Ther. 2017;11:305–312. doi:10.2147/DDDT.S124497
   PubMed Web of Science ®Google Scholar
• ChapaDW, AkintadeB, SonH, et al. Pathophysiological relationships between heart failure and depression and anxiety. Crit Care Nurse. 2014;34(2):14–24. doi:10.4037/ccn2014938
   PubMed Web of Science ®Google Scholar
• CullyJA, JimenezDE, LedouxTA, DeswalA. Recognition and treatment of depression and anxiety symptoms in heart failure. Prim Care Companion J Clin Psychiatry. 2009;11(3):103–109. doi:10.4088/pcc.08m0070019617942
   PubMedGoogle Scholar
• HöfflerD, MorgensternHO. Age dependence of therapy result and risk in the treatment of arterial hypertension? J Cardiovasc Pharmacol. 1990;16(Suppl 5):S184–S188. doi:10.1097/00005344-199000165-0003311527125
   PubMed Web of Science ®Google Scholar
• de FNJ, MadyC, GrupiC. Effects of metoprolol tartrate therapy in patients with heart failure. Arq Bras Cardiol. 2006;87(3):329–335. doi:10.1590/s0066-782x200600160001617057934
   PubMedGoogle Scholar
• ArslanS, ErolMK, GundogduF, et al. Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J. 2007;34(2):166–169.17622362
   PubMed Web of Science ®Google Scholar
• YangY-J, HeX-H, GuoH-Y, Wang X-QZY, ZhuY. Efficiency of muscle strength training on motor function in patients with coronary artery disease: a meta-analysis. Int J Clin Exp Med. 2015;8(10):17536–17550.26770345
   PubMed Web of Science ®Google Scholar
• KojovicJ, MiljkovicN, JankovicMM, PopovicDB. Recovery of motor function after stroke: a polymyography-based analysis. J Neurosci Methods. 2011;194(2):321–328. doi:10.1016/j.jneumeth.2010.10.00620951735
   PubMed Web of Science ®Google Scholar
• Sözeri-VarmaG. Depression in the Elderly: clinical Features and Risk Factors. Aging Dis. 2012;3(6):465–471.23251852
   PubMed Web of Science ®Google Scholar
• HekK, TiemeierH, NewsonRS, LuijendijkHJ, HofmanA, MulderCL. Anxiety disorders and comorbid depression in community dwelling older adults. Int J Methods Psychiatr Res. 2011;20(3):157–168. doi:10.1002/mpr.34422547298
   PubMed Web of Science ®Google Scholar
• ZhangQ, ShuQ, WuL, ZhangR, MengY. Dose-independent influence of metoprolol on cardiac and motor functions, QoL, and mental status in Chinese patients with CHF. Ther Clin Risk Manag. 2019;15:23–31. doi:10.2147/TCRM.S18812330588002
   PubMed Web of Science ®Google Scholar
• WerdanK, EbeltH, NudingS, HöpfnerF, StöcklG, Müller-WerdanU. ADDITIONS Study Investigators. Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial. Cardiology. 2016;133(2):83–90. doi:10.1159/00043958426501486
   PubMed Web of Science ®Google Scholar
• PetersDH, BenfieldP. Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy. Pharmacoeconomics. 1994;6(4):370–400. doi:10.2165/00019053-199406040-0000410147474
   PubMed Web of Science ®Google Scholar